Ketil André Camilio

706 total citations
13 papers, 537 citations indexed

About

Ketil André Camilio is a scholar working on Immunology, Molecular Biology and Microbiology. According to data from OpenAlex, Ketil André Camilio has authored 13 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Microbiology. Recurrent topics in Ketil André Camilio's work include Immunotherapy and Immune Responses (9 papers), Antimicrobial Peptides and Activities (7 papers) and RNA Interference and Gene Delivery (6 papers). Ketil André Camilio is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Antimicrobial Peptides and Activities (7 papers) and RNA Interference and Gene Delivery (6 papers). Ketil André Camilio collaborates with scholars based in Norway, Sweden and Denmark. Ketil André Camilio's co-authors include Øystein Rekdal, Baldur Sveinbjørnsson, Bengt Erik Haug, Gerd Marit Berge, Liv Tone Eliassen, Chandra Sekhar Ravuri, Gunnar Kvalheim, Mengyu Wang, Kristian Bartnes and Wenche Stensen and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Ketil André Camilio

12 papers receiving 530 citations

Peers

Countries citing papers authored by Ketil André Camilio

Since Specialization

Citations

This map shows the geographic impact of Ketil André Camilio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketil André Camilio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketil André Camilio more than expected).

Fields of papers citing papers by Ketil André Camilio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ketil André Camilio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketil André Camilio. The network helps show where Ketil André Camilio may publish in the future.

Co-authorship network of co-authors of Ketil André Camilio

This figure shows the co-authorship network connecting the top 25 collaborators of Ketil André Camilio. A scholar is included among the top collaborators of Ketil André Camilio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketil André Camilio. Ketil André Camilio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma 2023 ·OncoImmunology ·Morten Nielsen, (unknown), Vibeke Sundvold, (unknown), (unknown), Michael Mørk Petersen, Anders Krarup‐Hansen, Özcan Met, Ketil André Camilio, Trevor Clancy, Richard Stratford, Baldur Sveinbjørnsson, Øystein Rekdal, Niels Junker, Inge Marie Svane	20
2	Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer 2021 ·Scientific Reports ·Karianne G. Fleten, (unknown), (unknown), Ketil André Camilio, Terje Vasskog, Baldur Sveinbjørnsson, Øystein Rekdal, Gunhild M. Mælandsmo, Kjersti Flatmark	7
3	Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model 2019 ·Breast Cancer Research ·Ketil André Camilio, Mengyu Wang, (unknown), (unknown), Gunnar Kvalheim, Øystein Rekdal, Baldur Sveinbjørnsson, Gunhild M. Mælandsmo	52
4	The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma 2019 ·Molecular Therapy — Oncolytics ·(unknown), Ketil André Camilio, Jihua Shi, Clara Hammarström, Øystein Rekdal, Baldur Sveinbjørnsson, Pål‐Dag Line	16
5	Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts 2017 ·Scientific Reports ·(unknown), (unknown), Ketil André Camilio, Iñigo Martínez-Zubiaurre, Turid Hellevik	41
6	Abstract 11: The oncolytic peptide LTX-315 enhances T cell clonality and induces synergy with chemotherapy 2017 ·Cancer Research ·Ketil André Camilio, Meng Yu Wang, (unknown), Gunhild M. Mælandsmo, Baldur Sveinbjørnsson, Øystein Rekdal	0
7	LTX-315: A First-In-Class Oncolytic Peptide that Reprograms the Tumor Microenvironment 2017 ·Future Medicinal Chemistry ·(unknown), Ketil André Camilio, Bengt Erik Haug, Øystein Rekdal	67
8	Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model 2017 ·OncoImmunology ·(unknown), Mengyu Wang, Ketil André Camilio, (unknown), Torunn Elisabeth Tjelle, Alf A. Lindberg, Bengt Erik Haug, Gunnar Kvalheim, Baldur Sveinbjørnsson, Øystein Rekdal	43
9	The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma 2016 ·PLoS ONE ·(unknown), (unknown), Ketil André Camilio, Øystein Rekdal, Baldur Sveinbjørnsson	14
10	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide 2016 ·Journal of Medicinal Chemistry ·Bengt Erik Haug, Ketil André Camilio, Liv Tone Eliassen, Wenche Stensen, John S. Svendsen, (unknown), (unknown), Guillaume Serin, Jean‐François Mirjolet, Francis Bichat, Øystein Rekdal	95
11	Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315 2014 ·Cancer Immunology Immunotherapy ·Ketil André Camilio, Gerd Marit Berge, Chandra Sekhar Ravuri, Øystein Rekdal, Baldur Sveinbjørnsson	74
12	LTX-315 (Oncopore™) 2014 ·OncoImmunology ·Ketil André Camilio, Øystein Rekdal, Baldur Sveinbjørnsson	49
13	Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide 2010 ·Cancer Immunology Immunotherapy ·Gerd Marit Berge, Liv Tone Eliassen, Ketil André Camilio, Kristian Bartnes, Baldur Sveinbjørnsson, Øystein Rekdal	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact